Allschwil, Switzerland, April 09, 2024 Basilea Pharmaceutica Ltd, Allschwil , a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal.
Basilea Awarded CARB-X Grant To Develop Recently Acquired Novel Class Of Antibiotics menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Genevant secures $114M deal with Tome to develop liver therapy fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
Basilea Pharmaceutica AG (BPMUF, 0QNA.L), a Swiss commercial-stage biopharmaceutical company, Monday announced its asset purchase agreement with Spexis AG to acquire a preclinical program of antibiotics for up to a total of 2 million Swiss francs.
Basilea Pharmaceutica AG: Basilea announces acquisition of preclinical antibiotics program from Spexis finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.